STAT
NOVEMBER 3, 2022
A leaked draft version of a trade agreement being negotiated between the United Kingdom and India has sparked concern among civil society and patient advocacy groups that the proposed deal would impede the supply of affordable generic medicines in poor countries around the world.
Express Pharma
APRIL 11, 2023
The pundits are unanimous in their response – changes in the US generic drug market. The US is the biggest market for generic medicines (~90 per cent of prescriptions are fulfilled by generic drugs). should be completed before a new drug development is started.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
OCTOBER 10, 2023
The state’s biotech scene exploded in the mid-2010s and early in the pandemic as exuberant investors disregarded the high failure rate in drug development and bet on buzzy technologies such as gene editing and messenger RNA vaccines. “But I was confident I was going to find something else.”
European Pharmaceutical Review
JULY 25, 2023
The small molecule API market is influenced by several factors, including heightened R&D within the pharmaceutical sector, a growing prevalence of chronic illnesses and rising demand for generic medicines. This opportunity can lead to higher production and revenue, the research reported.
Pharmaceutical Technology
FEBRUARY 28, 2023
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.
Express Pharma
JULY 3, 2023
How is the industry’s approach to drug development transforming? How is Waters aiding advancements in drug development? A central aim in drug development is to create new molecular entities into commercially viable drugs useful in managing diseases. What are the imperatives that led to this change?
Express Pharma
NOVEMBER 1, 2024
In the marathon of drug development, where billions of dollars and over a decade of research are the norm, drug repurposing is quietly reshaping the landscape. Challenges in drug repurposing Despite these technological and regulatory advancements, the journey of drug repurposing is not without its challenges.
Expert insights. Personalized for you.
248 
Let's personalize your content